Skip to main content
. 2015 Jun 21;68(4):1243–1256. doi: 10.1007/s10616-015-9885-6

Table 2.

Effects of CAR treatments on pancreas SOD, CAT, GSH-PX activities and MDA levels in cerulein-induced AP

Groups SOD (U/mg-protein) mean ± SD CAT (U/mg-protein) mean ± SD GSH-PX (U/mg-protein) mean ± SD MDA (nmol/mg-protein) mean ± SD
Control 4.13 ± 0.18a 11.10 ± 0.53b,c 0.63 ± 0.05b,c 1.80 ± 0.21a
AP 3.11 ± 0.23c 2.85 ± 0.14e 0.11 ± 0.07f 2.99 ± 0.34c
CAR 50 mg/kg 4.15 ± 0.32a 11.17 ± 0.49a,b 0.67 ± 0.08a,b 1.75 ± 0.49a
CAR 100 mg/kg 4.25 ± 0.37a 11.31 ± 0.33a,b 0.69 ± 0.11a,b 1.83 ± 0.27a
CAR 200 mg/kg 4.30 ± 0.46a 12.20 ± 0.42a 0.89 ± 0.14a 1.81 ± 0.19a
AP + CAR 50 mg/kg 3.18 ± 0.15c 3.24 ± 0.20d,e 0.20 ± 0.13e 2.89 ± 0.38c
AP + CAR 100 mg/kg 3.23 ± 0.42b,c 4.11 ± 0.18d 0.32 ± 0.05d 2.79 ± 0.33b,c
AP + CAR 200 mg/kg 4.10 ± 0.24a,b 10.10 ± 0.43c 0.58 ± 0.14c 1.90 ± 0.40a,b

Data are presented as mean ± SD (n = 7). The means in the same column marked by different letters are significantly different (p < 0.05) from each other. For abbreviations see legend in Table 1